SCHEMBL23809196

SCHEMBL23809196

CCC(C)c1cccc2c1CCC2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 2/20 0.42
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
S1PR1 P21453 1/20 0.38
KRAS P01116 3/20 0.36
SOS1 Q07889 3/20 0.36
ABCB1 P08183 2/20 0.36
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
S100A4 P26447 1/20 0.35
KMT2A Q03164 1/20 0.35
TYMS P04818 1/20 0.34
PDE4D Q08499 1/20 0.33
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30872206 0.82 ALDH1A1 (0.40) ALDH1A1GAATSHRKDM4EHPGD
SCHEMBL9924223 0.82 ALDH1A1 (0.40) ALDH1A1GAATSHRKDM4EHPGD
SCHEMBL27531475 0.79 ALDH1A1 (0.38) ALDH1A1GAAKDM4EHPGDS1PR1
SCHEMBL8104228 0.76 ALDH1A1 (0.55) ALDH1A1GAATSHRKDM4EHPGD
SCHEMBL25628271 0.75 KRAS (0.43) ALDH1A1GAATSHRKDM4EHPGD
SCHEMBL287031 0.75 ALDH1A1 (0.42) ALDH1A1GAAKDM4EHPGDKRAS
SCHEMBL8200797 0.75 DPP4 (0.40) ALDH1A1GAATSHRKDM4EHPGD
SCHEMBL1151568 0.73 ALDH1A1 (0.59) ALDH1A1GAAKDM4EHPGDS1PR1
SCHEMBL10216198 0.72 CYP2A6 (0.44) TSHRKDM4EHPGDKMT2ATYMS
SCHEMBL27506477 0.72 ALDH1A1 (0.42) ALDH1A1GAATSHRKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 ALDH1A1 2556/4885GAA 3420/4885TSHR 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.